ALNY
Alnylam Pharmaceuticals Inc
Price:  
307.99 
USD
Volume:  
571,870.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Alnylam Fair Value

-109.27 %
Upside

What is the fair value of Alnylam?

As of 2025-06-15, the Fair Value of Alnylam Pharmaceuticals Inc (ALNY) is -28.56 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 307.99 USD, the upside of Alnylam Pharmaceuticals Inc is -109.27%.

Is Alnylam a good investment?

With the market price of 307.99 USD and our fair value calculation, Alnylam Pharmaceuticals Inc (ALNY) is not a good investment. Investing in Alnylam stocks now will result in a potential loss of 109.27%.

Note: valuation result may not be accurate due to the company's negative EPS.

307.99 USD
Stock Price
-28.56 USD
Fair Price
FAIR VALUE CALCULATION

Alnylam Fair Value

Peter Lynch's formula is:

Alnylam Fair Value
= Earnings Growth Rate x TTM EPS
Alnylam Fair Value
= 13.81 x -2.07
Alnylam Fair Value
= -28.56

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -858.30 -852.80 -1,131.20 -440.24 -278.16 -712.14
YoY growth 3.14% 0.64% -32.65% 61.08% 36.82% 13.81%

Alnylam Fair Value - Key Data

Market Cap (mil) 40,158.82
P/E
Forward P/E
EPS -2.07
Avg earnings growth rate 13.81%
TTM earnings -269.70